0.7356
price up icon1.22%   0.0089
pre-market  Vorhandelsmarkt:  .75   0.0144   +1.96%
loading
Schlusskurs vom Vortag:
$0.7267
Offen:
$0.73
24-Stunden-Volumen:
248.93K
Relative Volume:
0.10
Marktkapitalisierung:
$11.93M
Einnahmen:
$2.05M
Nettoeinkommen (Verlust:
$-23.15M
KGV:
-0.1109
EPS:
-6.6319
Netto-Cashflow:
$-16.93M
1W Leistung:
+1.48%
1M Leistung:
-4.59%
6M Leistung:
-76.04%
1J Leistung:
-66.71%
1-Tages-Spanne:
Value
$0.72
$0.738
1-Wochen-Bereich:
Value
$0.7159
$0.7479
52-Wochen-Spanne:
Value
$0.6358
$6.8908

iBio Inc Stock (IBIO) Company Profile

Name
Firmenname
iBio Inc
Name
Telefon
302-355-0650
Name
Adresse
600 Madison Avenue, Suite 1601, New York, NY
Name
Mitarbeiter
54
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
IBIO's Discussions on Twitter

Vergleichen Sie IBIO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
IBIO
iBio Inc
0.7356 11.76M 2.05M -23.15M -16.93M -6.6319
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

iBio Inc Stock (IBIO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-05-28 Eingeleitet Chardan Capital Markets Buy
2021-11-29 Eingeleitet JMP Securities Mkt Outperform
2021-01-22 Eingeleitet Cantor Fitzgerald Overweight
2020-06-26 Eingeleitet Alliance Global Partners Buy

iBio Inc Aktie (IBIO) Neueste Nachrichten

pulisher
03:07 AM

What analysts say about iBio Inc. stockHigh-profit trading signals - jammulinksnews.com

03:07 AM
pulisher
Jul 22, 2025

iBio Inc. Stock Analysis and ForecastFree Investment Case Studies - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is iBio Inc. a good long term investmentExplosive earning power - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives iBio Inc. stock priceSpectacular growth rates - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

how ibio stock performs during market volatilityFree Short-Term Stock Picks - Newser

Jul 19, 2025
pulisher
Jul 19, 2025

what makes ibio inc. stock price move sharplyFree Step-by-Step Investment Guide - Newser

Jul 19, 2025
pulisher
Jul 18, 2025

What institutions are buying iBio Inc. stock nowFree Access to Investment Community - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

Why iBio Inc. stock attracts strong analyst attentionFree Stock Selection with 300% Return - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes iBio Inc. stock price move sharplyChart Based Entries - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

IBIO’s Market Whiplash: -61.36% YTD Decline, -20.36% Plunge in 30 Days - investchronicle.com

Jul 15, 2025
pulisher
Jul 15, 2025

How iBio Inc. stock performs during market volatilityFree Access to Investors Club - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

iBio (NYSEMKT:IBIO) Stock Price Down 0% – What’s Next? - Defense World

Jul 11, 2025
pulisher
Jun 24, 2025

iBio stock soars after amylin receptor antibody shows promising results - Investing.com

Jun 24, 2025
pulisher
Jun 24, 2025

iBio Advances Obesity Care with Antibody Therapies - TipRanks

Jun 24, 2025
pulisher
Jun 24, 2025

iBio (IBIO) Reports Promising Preclinical Results in Obesity Stu - GuruFocus

Jun 24, 2025
pulisher
Jun 24, 2025

US Stocks Likely To Open Higher After Trump Announces Iran-Israel Ceasefire: FedEx, TD Synnex In Focus Ahead Of EarningsBlackBerry (NYSE:BB), Carnival (NYSE:CCL) - Benzinga

Jun 24, 2025
pulisher
Jun 23, 2025

iBio's Next-Gen Obesity Therapies: A Strategic Pipeline with Transformative Potential - AInvest

Jun 23, 2025
pulisher
Jun 19, 2025

iBio Extends Promissory Note Maturity to 2026 - TipRanks

Jun 19, 2025
pulisher
Jun 17, 2025

Ibio nominates IBIO-610 as obesity development candidate - BioWorld MedTech

Jun 17, 2025
pulisher
Jun 16, 2025

iBio initiates primate study for obesity antibody candidate IBIO-610 By Investing.com - Investing.com South Africa

Jun 16, 2025
pulisher
Jun 16, 2025

iBio (IBIO) Begins Preclinical Study of New Antibody Candidate | - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

iBio initiates primate study for obesity antibody candidate IBIO-610 - Investing.com

Jun 16, 2025
pulisher
Jun 16, 2025

iBio Initiates Non-Human Primate Study of First-in-Class Activin E Antibody Following Positive Preclinical Data Demonstrating Prevention in Weight Regain After GLP-1 Treatment | IBIO Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

iBio initiates non-human primate study of IBIO-610 - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

iBio Initiates Non-Human Primate Study of First-in-Class Activin E Antibody Following Positive Preclinical Data Demonstrating Prevention in Weight Regain After GLP-1 Treatment - The Manila Times

Jun 16, 2025
pulisher
Jun 16, 2025

Breakthrough Obesity Drug Shows 77% Fat Reduction When Combined With GLP-1 Treatments - Stock Titan

Jun 16, 2025
pulisher
Jun 13, 2025

iBio (IBIO) Plans to Offer 11.25 Million Shares of Common Stock - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Sector Update: Health Care - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

IBio Files Prospectus for Resale of About 11.3 Million Shares - marketscreener.com

Jun 13, 2025
pulisher
Jun 10, 2025

Plant-Based Vaccines Market Future Business Opportunities 2025-2032 | Medicago, Inc., IBIO, Icon Genetics GmbH - newstrail.com

Jun 10, 2025
pulisher
May 29, 2025

iBio: University of Limerick programme to ‘shape the next generation’ of pharmaceutical manufacturing experts - University of Limerick

May 29, 2025
pulisher
May 23, 2025

Merck & Co., Inc. (MRK): A Bull Case Theory - MSN

May 23, 2025
pulisher
May 14, 2025

Plant-Based Vaccines Market Detailed In New Research Report - openPR.com

May 14, 2025
pulisher
May 11, 2025

Insiders Who Purchased US$655.0k Of iBio Stock May Not Have Expected 23% Tumble - simplywall.st

May 11, 2025
pulisher
May 11, 2025

Insider Buyers At iBio Likely Disappointed With 23% Slide - Yahoo Finance

May 11, 2025
pulisher
May 11, 2025

Chardan Capital Has Pessimistic View of iBio FY2025 Earnings - Defense World

May 11, 2025
pulisher
May 09, 2025

Chardan Capital Has Bearish Outlook for iBio FY2025 Earnings - Defense World

May 09, 2025
pulisher
May 07, 2025

Would I Consider iBio Inc (NASDAQ: IBIO) Stock Any Time In The Future? - Stocksregister

May 07, 2025
pulisher
May 06, 2025

Balance Sheet Dive: iBio Inc (IBIO)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX

May 06, 2025

Finanzdaten der iBio Inc-Aktie (IBIO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):